Halozyme To Present At Upcoming Virtual Investor Conferences
- Wednesday, September 9, 2020, 7:13
- Business
- Add a comment
SAN DIEGO, Sept. 9, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the following investor conferences: Cantor Virtual Global Healthcare Conference at 10:40 a.m. ET /…
About the Author
adminasapcorp has written 41546 stories on this site.